BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33964364)

  • 1. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
    Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
    J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies: a promising approach to treatment of viral diseases.
    Minatel VM; Prudencio CR; Barraviera B; Ferreira RS
    Front Immunol; 2023; 14():1303353. PubMed ID: 38322011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobodies: The Future of Antibody-Based Immune Therapeutics.
    Bathula NV; Bommadevara H; Hayes JM
    Cancer Biother Radiopharm; 2021 Mar; 36(2):109-122. PubMed ID: 32936001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Insights into the Design of Synthetic Nanobody Libraries.
    Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
    Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
    Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobodies: Robust miniprotein binders in biomedicine.
    Yong Joon Kim J; Sang Z; Xiang Y; Shen Z; Shi Y
    Adv Drug Deliv Rev; 2023 Apr; 195():114726. PubMed ID: 36754285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Antibody and Nanobody Tools for P2X7.
    Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
    Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties, production, and applications of camelid single-domain antibody fragments.
    Harmsen MM; De Haard HJ
    Appl Microbiol Biotechnol; 2007 Nov; 77(1):13-22. PubMed ID: 17704915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.